亚洲最大的种植牙企业，韩国上市公司…
来源：the investor
以下来自谷歌翻译：
KRX 推迟解除 Osstem Implant 的交易暂停
韩国交易所，于周二(3月29日)表示，已决定推迟是否允许 Osstem Implant 恢复交易的决定，尽管经过数小时的审议未能就该公司的命运达成共识，该公司报告的内幕盗窃金额达 2210 亿韩元（ 1.81 亿美元）。
亚太地区最大的牙科植入物制造商曾在以科技股为主的科斯达克板交易，今年 1 月 3 日韩国证券交易所暂停交易时面临退市。
一个月后，交易所运营商对该公司进行了审查，以解除交易暂停或给予一年的宽限期。
“一旦我们在外部专家的帮助下检查其内部监督和新的公司治理，我们将重新评估该公司继续交易的资格，”韩国证券交易所在一份声明中表示。
这家植入物制造商最近组建了一个监督委员会和独立董事。
交易所运营商没有说明何时召开下一次会议以做出决定。
即使该公司恢复交易，预计该公司的股价也会暴跌。
KRX delays lifting trading halt at Osstem Implant
PUBLISHED : March 30, 2022 – 09:42
The Korea Exchange said Tuesday that it had decided to postpone its decision on whether to allow Osstem Implant to resume trading, despite hours of deliberation that failed to reach consensus on the fate of the company, which had reported insider theft amounting to 221 billion won ($181 million).
The largest dental implant maker in the Asia-Pacific region, which used to trade on the tech-heavy Kosdaq board, faced delisting on Jan. 3 this year when the KRX suspended trading. A month later, the bourse operator put the firm under review to either lift the trading halt or grant it a one-year grace period.
“We will reassess the firm’s qualification to continue trading once we check up on its internal oversight and a new corporate governance, with help from outside experts,” the KRX said in a statement. The implant maker recently put together an oversight committee and independent directors.
The bourse operator did not say when it would convene the next meeting to deliver the decision. The firm is expected to see a plunge in share prices, even if it were to resume trading.
By Choi Si-young (siyoungchoi@heraldcorp.com)
版权声明：所有「牙牙在线」的原创文章，转载须联系授权，并在文首/文末注明来源、作者、微信ID，否则我们将向其追究法律责任。部分文章推送时未能与原作者或公众号平台取得联系。若涉及版权问题，敬请原作者联系我们。